| # | Drug | Count |
|---|---|---|
| 0 | RUXOLITINIB | 120 |
| 1 | CYCLOPHOSPHAMIDE | 73 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 73 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 73 |
| 4 | RITUXIMAB | 60 |
| 5 | HYDROXYUREA | 52 |
| 6 | PREDNISONE | 51 |
| 7 | ASPIRIN | 42 |
| 8 | ASPIRIN 325 MG | 42 |
| 9 | ASPIRIN 81 MG | 42 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANAGRELIDE HYDROCHLORIDE | 7 | 0.0060 |
| 1 | HYDROXYUREA | 52 | 0.0024 |
| 2 | DECITABINE | 10 | 0.0023 |
| 3 | RUXOLITINIB | 120 | 0.0016 |
| 4 | PACRITINIB | 5 | 0.0016 |
| 5 | FEDRATINIB HYDROCHLORIDE | 2 | 0.0015 |
| 6 | BREXUCABTAGENE AUTOLEUCEL | 3 | 0.0014 |
| 7 | DORAVIRINE | 1 | 0.0013 |
| 8 | LUSPATERCEPT | 3 | 0.0011 |
| 9 | AXICABTAGENE CILOLEUCEL | 11 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 157 |
| 1 | Janus Kinase Inhibitor [EPC] | 134 |
| 2 | Corticosteroid [EPC] | 119 |
| 3 | Alkylating Drug [EPC] | 82 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 66 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 63 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 56 |
| 7 | Antimetabolite [EPC] | 52 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 43 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 42 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 8 | 0.0014 |
| 2 | Erythroid Maturation Agent [EPC] | 3 | 0.0011 |
| 3 | CD19-directed Chimeric Antigen Receptor [EPC] | 11 | 0.0011 |
| 4 | Interferon alfa-2b [EPC] | 2 | 0.0011 |
| 5 | Janus Kinase Inhibitor [EPC] | 134 | 0.0008 |
| 6 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 7 | Provitamin D2 Compound [EPC] | 17 | 0.0006 |
| 8 | Thrombopoietin Receptor Agonist [EPC] | 8 | 0.0005 |
| 9 | Nuclear Export Inhibitor [EPC] | 4 | 0.0005 |